{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:24:42Z","timestamp":1782221082455,"version":"3.54.5"},"reference-count":82,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T00:00:00Z","timestamp":1604275200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Arch Virol"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1007\/s00705-020-04860-8","type":"journal-article","created":{"date-parts":[[2020,11,2]],"date-time":"2020-11-02T09:02:49Z","timestamp":1604307769000},"page":"1-7","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":42,"title":["Tetracycline and viruses: a possible treatment for COVID-19?"],"prefix":"10.1007","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1496-5511","authenticated-orcid":false,"given":"Jes\u00fas A.","family":"Mosquera-Sulbaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hugo","family":"Hern\u00e1ndez-Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2020,11,2]]},"reference":[{"key":"4860_CR1","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1111\/j.1749-6632.1948.tb27262.x","volume":"51","author":"BM Duggar","year":"1948","unstructured":"Duggar BM (1948) Aureomycin: a product of the continuing search for new antibiotics. Ann NY Acad Sci 51:177\u2013181. https:\/\/doi.org\/10.1111\/j.1749-6632.1948.tb27262.x","journal-title":"Ann NY Acad Sci"},{"key":"4860_CR2","doi-asserted-by":"publisher","first-page":"301","DOI":"10.2165\/00128072-200305050-00003","volume":"5","author":"V Goulden","year":"2003","unstructured":"Goulden V (2003) Guidelines for the management of acne vulgaris in adolescents. Paediatr Drugs 5:301\u2013313. https:\/\/doi.org\/10.2165\/00128072-200305050-00003","journal-title":"Paediatr Drugs"},{"key":"4860_CR3","doi-asserted-by":"publisher","first-page":"727","DOI":"10.4065\/74.7.727","volume":"74","author":"JD Smilack","year":"1999","unstructured":"Smilack JD (1999) The tetracyclines. Mayo Clin Proc 74:727\u2013729. https:\/\/doi.org\/10.4065\/74.7.727","journal-title":"Mayo Clin Proc"},{"key":"4860_CR4","doi-asserted-by":"publisher","first-page":"852","DOI":"10.1002\/cpt1973145852","volume":"14","author":"H Macdonald","year":"1973","unstructured":"Macdonald H, Kelly RG, Allen ES, Noble JF, Kanegis LA (1973) Pharmacokinetic studies on minocycline in man. Clin Pharmacol Ther 14:852\u2013861. https:\/\/doi.org\/10.1002\/cpt1973145852","journal-title":"Clin Pharmacol Ther"},{"key":"4860_CR5","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1111\/j.1440-1681.1974.tb00552.x","volume":"1","author":"S Carney","year":"1974","unstructured":"Carney S, Butcher RA, Dawborn JK, Pattison G (1974) Minocycline excretion and distribution in relation to renal function in man. Clin Exp Pharmacol Physiol 1:299\u2013308. https:\/\/doi.org\/10.1111\/j.1440-1681.1974.tb00552.x","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"4860_CR6","doi-asserted-by":"publisher","first-page":"1045","DOI":"10.1016\/S1474-4422(07)70270-3","volume":"6","author":"PH Gordon","year":"2007","unstructured":"Gordon PH, Moore DH, Miller RG, Florence JM, Verheijde JL, Doorish C (2007) Efficacy of minocycline in patients with amyotrophic lateral sclerosis: a phase III randomised trial. Lancet Neurol 6:1045\u20131053. https:\/\/doi.org\/10.1016\/S1474-4422(07)70270-3","journal-title":"Lancet Neurol"},{"key":"4860_CR7","doi-asserted-by":"publisher","first-page":"1404","DOI":"10.1212\/01.wnl.0000277487.04281.db","volume":"69","author":"Y Lampl","year":"2007","unstructured":"Lampl Y, Boaz M, Gilad R, Lorberboym M, Dabby R, Rapoport A (2007) Minocycline treatment in acute stroke: an open-label, evaluator-blinded study. Neurology 69:1404\u20131410. https:\/\/doi.org\/10.1212\/01.wnl.0000277487.04281.db","journal-title":"Neurology"},{"key":"4860_CR8","doi-asserted-by":"publisher","first-page":"679","DOI":"10.2174\/1381612043453162","volume":"10","author":"M Thomas","year":"2004","unstructured":"Thomas M, Le WD (2004) Minocycline: neuroprotective mechanisms in Parkinson\u2019s disease. Curr Pharm Des 10:679\u2013686. https:\/\/doi.org\/10.2174\/1381612043453162","journal-title":"Curr Pharm Des"},{"key":"4860_CR9","doi-asserted-by":"publisher","first-page":"517","DOI":"10.1177\/1352458506070319","volume":"13","author":"RK Zabad","year":"2007","unstructured":"Zabad RK, Metz LM, Todoruk TR, Zhang Y, Mitchell JR, Yeung M (2007) The clinical response to minocycline in multiple sclerosis is accompanied by beneficial immune changes: a pilot study. Mult Scler 13:517\u2013526. https:\/\/doi.org\/10.1177\/1352458506070319","journal-title":"Mult Scler"},{"key":"4860_CR10","doi-asserted-by":"publisher","first-page":"445","DOI":"10.1185\/03007997309111706","volume":"1","author":"A Michalopoulos","year":"1973","unstructured":"Michalopoulos A (1973) A clinical and laboratory study of doxycycline (\u2018Vibramycin\u2019): a broad-spectrum antibiotic. Curr Med Res Opin 1:445\u2013455. https:\/\/doi.org\/10.1185\/03007997309111706","journal-title":"Curr Med Res Opin"},{"key":"4860_CR11","first-page":"1033","volume":"64","author":"G Pulverer","year":"1969","unstructured":"Pulverer G (1969) Doxycycline-a broad spectrum antibiotic of the tetracycline series. Med Klin 64:1033\u20131037","journal-title":"Med Klin"},{"key":"4860_CR12","doi-asserted-by":"publisher","first-page":"3630","DOI":"10.1128\/aac.47.11.3630-3633.2003","volume":"47","author":"T Krakauer","year":"2003","unstructured":"Krakauer T, Buckley M (2003) Doxycycline is anti-inflammatory and inhibits staphylococcal exotoxin-induced cytokines and chemokines. Antimicrob Agents Chem 47:3630\u20133633. https:\/\/doi.org\/10.1128\/aac.47.11.3630-3633.2003","journal-title":"Antimicrob Agents Chem"},{"key":"4860_CR13","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1902\/jop.2008.080051","volume":"79","author":"J Cazalis","year":"2008","unstructured":"Cazalis J, Bodet C, Gagnon G (2008) Doxycycline reduces lipopolysaccharide-induced inflammatory mediator secretion in macrophage and ex vivo human whole blood models. J Periodontol 79:1762\u20131768. https:\/\/doi.org\/10.1902\/jop.2008.080051","journal-title":"J Periodontol"},{"key":"4860_CR14","doi-asserted-by":"publisher","first-page":"1421","DOI":"10.1001\/archinte.1997.00440340035003","volume":"157","author":"NJ Joshi","year":"1997","unstructured":"Joshi NJ, Miller D (1997) Doxycycline revisited. Arch Intern Med 157:1421\u20131428","journal-title":"Arch Intern Med"},{"key":"4860_CR15","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/S0021-9258(18)91306-2","volume":"239","author":"JH Hash","year":"1964","unstructured":"Hash JH, Wishnick M, Miller PA (1964) On the mode of action of the tetracycline antibiotics in Staphylococcus aureus. J Biol Chem 239:2070\u20132078","journal-title":"J Biol Chem"},{"key":"4860_CR16","doi-asserted-by":"publisher","first-page":"4133","DOI":"10.1021\/bi00637a029","volume":"16","author":"TR Tritton","year":"1977","unstructured":"Tritton TR (1977) Ribosome-tetracycline interactions. Biochemistry 16:4133\u20134138. https:\/\/doi.org\/10.1021\/bi00637a029","journal-title":"Biochemistry"},{"key":"4860_CR17","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1016\/0014-5793(82)80584-x","volume":"144","author":"YP Semenkov","year":"1982","unstructured":"Semenkov YP, Makarov EM, Makhno VI, Kirillov SV (1982) Kinetic aspects of tetracycline action on the acceptor (A) site of Escherichia coli ribosomes. FEBS Lett 144:125\u2013129. https:\/\/doi.org\/10.1016\/0014-5793(82)80584-x","journal-title":"FEBS Lett"},{"key":"4860_CR18","doi-asserted-by":"publisher","first-page":"3063","DOI":"10.1161\/01.cir.99.23.3063","volume":"99","author":"LE Rohde","year":"1999","unstructured":"Rohde LE, Ducharme A, Arroyo LH, Aikawa M, Sukhova GH, Lopez-Anaya A, McClure KF, Mitchell PG, Libby P, Lee RT (1999) Matrix metalloproteinase inhibition attenuates early left ventricular enlargement after experimental myocardial infarction in mice. Circulation 99:3063\u20133070. https:\/\/doi.org\/10.1161\/01.cir.99.23.3063","journal-title":"Circulation"},{"key":"4860_CR19","doi-asserted-by":"publisher","first-page":"63","DOI":"10.1023\/B:HREV.0000011395.11179.af","volume":"9","author":"JT Peterson","year":"2004","unstructured":"Peterson JT (2004) Matrix metalloproteinase inhibitor development and the remodeling of drug discovery. Heart Fail Rev 9:63\u201379. https:\/\/doi.org\/10.1023\/B:HREV.0000011395.11179.af","journal-title":"Heart Fail Rev"},{"key":"4860_CR20","doi-asserted-by":"publisher","first-page":"21491","DOI":"10.1074\/jbc.274.31.21491","volume":"274","author":"H Nagase","year":"1999","unstructured":"Nagase H, Woessner JF (1999) Matrix metalloproteinases. J Biol Chem 274:21491\u201321494. https:\/\/doi.org\/10.1074\/jbc.274.31.21491","journal-title":"J Biol Chem"},{"key":"4860_CR21","doi-asserted-by":"publisher","first-page":"C539","DOI":"10.1152\/ajpcell.00047.2010","volume":"299","author":"MO Griffin","year":"2010","unstructured":"Griffin MO, Fricovsky E, Ceballos G, Villarreal F (2010) Tetracyclines: a pleitropic family of compounds with promising therapeutic properties. Review of the literature. Am J Physiol Cell Physiol 299:C539\u2013C548. https:\/\/doi.org\/10.1152\/ajpcell.00047.2010","journal-title":"Am J Physiol Cell Physiol"},{"key":"4860_CR22","doi-asserted-by":"publisher","first-page":"1905","DOI":"10.1016\/s0003-4975(99)01073-5","volume":"68","author":"JL Park","year":"1999","unstructured":"Park JL, Lucchesi BR (1999) Mechanisms of myocardial reperfusion injury. Ann Thorac Surg 68:1905\u20131912. https:\/\/doi.org\/10.1016\/s0003-4975(99)01073-5","journal-title":"Ann Thorac Surg"},{"key":"4860_CR23","doi-asserted-by":"publisher","first-page":"819","DOI":"10.1111\/j.1471-4159.2005.03219.x","volume":"94","author":"RL Kraus","year":"2005","unstructured":"Kraus RL, Pasieczny R, Lariosa-Willingham K, Turner MS, Jiang A, Trauger JW (2005) Antioxidant properties of minocycline: neuroprotection in an oxidative stress assay and direct radical-scavenging activity. J Neurochem 94:819\u2013827. https:\/\/doi.org\/10.1111\/j.1471-4159.2005.03219.x","journal-title":"J Neurochem"},{"key":"4860_CR24","doi-asserted-by":"publisher","first-page":"10849","DOI":"10.1073\/pnas.162195499","volume":"99","author":"G Forloni","year":"2002","unstructured":"Forloni G, Iussich S, Awan T, Colombo L, Angeretti N, Girola L, Bertani I, Poli G, Caramell M, Grazia Bruzzone M, Farina L, Limido L, Rossi G, Giaccone G, Ironside JW, Bugiani O, Salmona M (2002) Tetracyclines affect prion infectivity. Proc Natl Acad Sci USA 99:10849\u201310854. https:\/\/doi.org\/10.1073\/pnas.162195499","journal-title":"Proc Natl Acad Sci USA"},{"key":"4860_CR25","doi-asserted-by":"publisher","first-page":"2861","DOI":"10.1038\/sj.onc.1207523","volume":"23","author":"X Saelens","year":"2004","unstructured":"Saelens X, Festjens N, Vande Walle L, van Gurp M, van Loo G, Vandenabeele P (2004) Toxic proteins released from mitochondria in cell death. Oncogene 23:2861\u20132874. https:\/\/doi.org\/10.1038\/sj.onc.1207523","journal-title":"Oncogene"},{"key":"4860_CR26","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.cellsig.2003.08.007","volume":"16","author":"A Thorburn","year":"2004","unstructured":"Thorburn A (2004) Death receptor-induced cell killing. Cell Signal 16:139\u2013144. https:\/\/doi.org\/10.1016\/j.cellsig.2003.08.007","journal-title":"Cell Signal"},{"key":"4860_CR27","doi-asserted-by":"publisher","first-page":"15769","DOI":"10.1073\/pnas.95.26.15769","volume":"95","author":"J Yrj\u00e4nheikki","year":"1998","unstructured":"Yrj\u00e4nheikki J, Kein\u00e4nen R, Pellikka M, H\u00f6kfelt T, Koistinaho J (1998) Tetracyclines inhibit microglial activation and are neuroprotective in global brain ischemia. Proc Natl Acad Sci USA 95:15769\u201315774. https:\/\/doi.org\/10.1073\/pnas.95.26.15769","journal-title":"Proc Natl Acad Sci USA"},{"key":"4860_CR28","doi-asserted-by":"publisher","first-page":"1393","DOI":"10.1097\/00006123-200106000-00051","volume":"48","author":"RO Sanchez Mejia","year":"2001","unstructured":"Sanchez Mejia RO, Ona VO, Li M, Friedlander RM (2001) Minocycline reduces traumatic brain injury-mediated caspase-1 activation, tissue damage, and neurological dysfunction. Neurosurgery 48:1393\u20131399. https:\/\/doi.org\/10.1097\/00006123-200106000-00051","journal-title":"Neurosurgery"},{"key":"4860_CR29","doi-asserted-by":"publisher","first-page":"14669","DOI":"10.1073\/pnas.251341998","volume":"98","author":"Y Du","year":"2001","unstructured":"Du Y, Ma Z, Lin S, Dodel RC, Gao F, Bales KR, Triarhou LC, Chernet E, Perry KW, Nelson DL, Luecke S, Phebus LA, Bymaster FP, Paul SM (2001) Minocycline prevents nigrostriatal dopaminergic neurodegeneration in the M.PTP model of Parkinson\u2019s disease. Proc Natl Acad Sci USA 98:14669\u201314674. https:\/\/doi.org\/10.1073\/pnas.251341998","journal-title":"Proc Natl Acad Sci USA"},{"key":"4860_CR30","doi-asserted-by":"publisher","DOI":"10.1038\/77528","author":"M Chen","year":"2000","unstructured":"Chen M, Ona VO, Li M, Ferrante RJ, Fink KB, Zhu S (2000) Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease. Nat Med. https:\/\/doi.org\/10.1038\/77528","journal-title":"Nat Med"},{"key":"4860_CR31","doi-asserted-by":"publisher","first-page":"10483","DOI":"10.1073\/pnas.1832501100","volume":"100","author":"X Wang","year":"2003","unstructured":"Wang X, Zhu S, Drozda M, Zhang W, Stavrovskaya IG, Cattaneo E, Ferrante RJ, Kristal BS, Friedlander RM (2003) Minocycline inhibits caspase-independent and -dependent mitochondrial cell death pathways in models of Huntington\u2019s disease. Proc Natl Acad Sci USA 100:10483\u201310487. https:\/\/doi.org\/10.1073\/pnas.1832501100","journal-title":"Proc Natl Acad Sci USA"},{"key":"4860_CR32","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.1016\/0006-2952(92)90381-r","volume":"44","author":"W Pruzanski","year":"1992","unstructured":"Pruzanski W, Greenwald RA, Street IO, La-leberte F, Stefanski E, Vadas P (1992) Inhibition of enzymatic activity of phospholipase A2 by minocycline and doxycycline. Biochem Pharmacol 44:1165\u20131170. https:\/\/doi.org\/10.1016\/0006-2952(92)90381-r","journal-title":"Biochem Pharmacol"},{"key":"4860_CR33","doi-asserted-by":"publisher","first-page":"1308","DOI":"10.1001\/archderm.1984.01650460048018","volume":"120","author":"NB Esterly","year":"1984","unstructured":"Esterly NB, Koransky JS, Furey NL, Trevisan M (1984) Neutrophil chemotaxis in patients with acne receiving oral tetracycline therapy. Arch Dermatol 120:1308\u20131313","journal-title":"Arch Dermatol"},{"key":"4860_CR34","first-page":"131","volume":"74","author":"WL Gable","year":"1991","unstructured":"Gable WL, Tsukuda N (1991) The influence of divalent cations and doxycycline on iodoacetamide-inhibitable leukocyte adherence. Res Commun Chem Pathol Pharmacol 74:131\u2013140","journal-title":"Res Commun Chem Pathol Pharmacol"},{"key":"4860_CR35","first-page":"443","volume":"35","author":"YH Thong","year":"1979","unstructured":"Thong YH, Ferrante A (1979) Inhibition of mitogen-induced human lymphocyte proliferative responses by tetracycline analogues. Clin Exp Immunol 35:443\u2013446","journal-title":"Clin Exp Immunol"},{"key":"4860_CR36","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1158\/1541-7786.MCR-13-0239","volume":"11","author":"P Ataie-Kachoie","year":"2013","unstructured":"Ataie-Kachoie P, Badar S, Morris DL, Pourgholami MH (2013) Signal transduction minocycline targets the NF-kB nexus through suppression of TGF-b1-TAK1-IkB signaling in Ovarian cancer. Mol Cancer Res 11:1279\u20131291. https:\/\/doi.org\/10.1158\/1541-7786.MCR-13-0239","journal-title":"Mol Cancer Res"},{"key":"4860_CR37","doi-asserted-by":"publisher","first-page":"397","DOI":"10.1016\/j.bbrep.2015.11.003","volume":"4","author":"J Sun","year":"2015","unstructured":"Sun J, Shigemi H, Tanaka Y, Yamauchi T, Ueda T, Iwasaki H (2015) Tetracyclines downregulate the production of LPS-induced cytokines and chemokines in THP-1 cells via ERK, p38, and nuclear factor-\u03baB signaling pathways. Biochem Biophy Rep 4:397\u2013404. https:\/\/doi.org\/10.1016\/j.bbrep.2015.11.003","journal-title":"Biochem Biophy Rep"},{"key":"4860_CR38","first-page":"13","volume":"1","author":"A Negrette","year":"1960","unstructured":"Negrette A (1960) Encefalitis epid\u00e9mica. Invest Clin 1:13\u201334","journal-title":"Invest Clin"},{"key":"4860_CR39","first-page":"11","volume":"15","author":"A Negrette","year":"1974","unstructured":"Negrette A, Mosquera J (1974) Epidemia de encefalitis de 1959 en Maracaibo (San Francisco), Estado Zulia, Venezuela. Manifestaciones cl\u00ednicas y terap\u00e9utica antibi\u00f3tica. Invest Clin 15:11\u201344","journal-title":"Invest Clin"},{"key":"4860_CR40","first-page":"49","volume":"5","author":"A Negrette","year":"1964","unstructured":"Negrette A, Maso-Dominguez J, Rolling CL (1964) Mononucleosis Infecciosa epid\u00e9mica. Invest Clin 5:49\u201353","journal-title":"Invest Clin"},{"key":"4860_CR41","first-page":"97","volume":"26","author":"A Negrette","year":"1968","unstructured":"Negrette A (1968a) Encefalitis equina venezolana. Leucocitos vacuolados. Invest Clin 26:97\u2013107","journal-title":"Invest Clin"},{"key":"4860_CR42","first-page":"5","volume":"26","author":"A Negrette","year":"1968","unstructured":"Negrette A (1968b) Par\u00e1lisis facial y tetraciclina. Invest Clin 26:5\u20136","journal-title":"Invest Clin"},{"key":"4860_CR43","first-page":"235","volume":"21","author":"A Negrette","year":"1980","unstructured":"Negrette A (1980) Tetraciclina y virus peque\u00f1os. Editorial. Invest Clin 21:235\u2013238","journal-title":"Invest Clin"},{"key":"4860_CR44","first-page":"117","volume":"31","author":"A Negrette","year":"1990","unstructured":"Negrette A (1990) Tetraciclina y Sida. Invest Clin 31:117\u2013119","journal-title":"Invest Clin"},{"key":"4860_CR45","first-page":"45","volume":"15","author":"A Negrette","year":"1974","unstructured":"Negrette A, Hernandez H (1974) Therapeutic effect of tetracycline in the experimental venezuelan encephalitis. Invest Clin 15:45\u201351","journal-title":"Invest Clin"},{"key":"4860_CR46","first-page":"7","volume":"36","author":"A Negrette","year":"1970","unstructured":"Negrette A, Escalona A, Ryder S (1970) Acci\u00f3n de la tetraciclina sobre la encefalitis aenezolana experimental. Comunicacion preliminar. Invest Clin 36:7\u201311","journal-title":"Invest Clin"},{"key":"4860_CR47","doi-asserted-by":"publisher","first-page":"5","DOI":"10.1016\/0923-2516(90)90052-k","volume":"141","author":"M Lemaitre","year":"1990","unstructured":"Lemaitre M, Guetard D, Henin Y, Montagnier L, Zerial A (1990) Protective activity of tetracycline analogs against the cytopathic effect of the human immunodeficiency viruses in CEM cells. Res Virol 141:5\u201316. https:\/\/doi.org\/10.1016\/0923-2516(90)90052-k","journal-title":"Res Virol"},{"key":"4860_CR48","doi-asserted-by":"publisher","first-page":"284","DOI":"10.1080\/13550280490499533","volume":"10","author":"Q Si","year":"2004","unstructured":"Si Q, Cosenza M, Kim MO, Zhao ML, Brownlee M, Goldstein H (2004) A novel action of minocycline: inhibition of human immunodeficiency virus type 1 infection in microglia. J Neurovirol 10:284\u2013292. https:\/\/doi.org\/10.1080\/13550280490499533","journal-title":"J Neurovirol"},{"key":"4860_CR49","doi-asserted-by":"publisher","first-page":"2003","DOI":"10.1001\/jama.293.16.2003","volume":"293","author":"MC Zink","year":"2005","unstructured":"Zink MC, Uhrlaub J, DeWitt J, Voelker T, Bullock B, Mankowski J (2005) Neuroprotective and anti-human immunodeficiency virus activity of minocycline. JAMA 293:2003\u20132011. https:\/\/doi.org\/10.1001\/jama.293.16.2003","journal-title":"JAMA"},{"key":"4860_CR50","doi-asserted-by":"publisher","first-page":"376","DOI":"10.1080\/13550280802199898","volume":"14","author":"SC Follstaedt","year":"2008","unstructured":"Follstaedt SC, Barber SA, Zink MC (2008) Mechanisms of minocycline-induced suppression of simian immunodeficiency virus encephalitis: inhibition of apoptosis signal-regulating kinase 1. J Neurovirol 14:376\u2013388. https:\/\/doi.org\/10.1080\/13550280802199898","journal-title":"J Neurovirol"},{"key":"4860_CR51","doi-asserted-by":"publisher","first-page":"2797","DOI":"10.1093\/bioinformatics\/btm424","volume":"23","author":"E Jenwitheesuk","year":"2007","unstructured":"Jenwitheesuk E, Samudrala R (2007) Identification of potential HIV-1 targets of minocycline. Bioinformatics 23:2797\u20132799. https:\/\/doi.org\/10.1093\/bioinformatics\/btm424","journal-title":"Bioinformatics"},{"key":"4860_CR52","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1093\/jac\/dkm307","volume":"60","author":"M Michaelis","year":"2007","unstructured":"Michaelis M, Kleinschmidt MC, Doerr HW, Cinat J (2007) Minocycline inhibits West Nile virus replication and apoptosis in human neuronal cells. J Antimicrob Chemother 60:981\u2013986. https:\/\/doi.org\/10.1093\/jac\/dkm307","journal-title":"J Antimicrob Chemother"},{"key":"4860_CR53","doi-asserted-by":"publisher","first-page":"1582","DOI":"10.1111\/j.1471-4159.2008.05238.x","volume":"105","author":"MK Mishra","year":"2008","unstructured":"Mishra MK, Basu A (2008) Minocycline neuroprotects, reduces microglial activation, inhibits caspase 3 induction, and viral replication following Japanese encephalitis. J Neurochem 105:1582\u20131595. https:\/\/doi.org\/10.1111\/j.1471-4159.2008.05238.x","journal-title":"J Neurochem"},{"key":"4860_CR54","doi-asserted-by":"publisher","first-page":"28","DOI":"10.1016\/j.antiviral.2018.05.002","volume":"155","author":"YC Lai","year":"2018","unstructured":"Lai YC, Chuang YC, Chang CP, Lin YS, Perng GC, Wu HC, Hsieh SL, Yeh TM (2018) Minocycline suppresses dengue virus replication by down-regulation of macrophage migration inhibitory factor-induced autophagy. Antiviral Res 155:28\u201338. https:\/\/doi.org\/10.1016\/j.antiviral.2018.05.002","journal-title":"Antiviral Res"},{"key":"4860_CR55","doi-asserted-by":"publisher","first-page":"e00569","DOI":"10.1128\/JVI.00569-17","volume":"91","author":"ED Quick","year":"2017","unstructured":"Quick ED, Seitz S, Clarke P, Tyler KL (2017) Minocycline has anti-inflammatory effects and reduces cytotoxicity in an Ex Vivo spinal cord slice culture model of west Nile virus infection. J Virol 91:e00569-e1517. https:\/\/doi.org\/10.1128\/JVI.00569-17","journal-title":"J Virol"},{"key":"4860_CR56","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1097\/01.jnen.0000263867.46070.e2","volume":"66","author":"DN Irani","year":"2007","unstructured":"Irani DN, Prow NA (2007) Neuroprotective interventions targeting detrimental host immune responses protect mice from fatal alphavirus encephalitis. J Neuropathol Exp Neurol 66:533\u2013544. https:\/\/doi.org\/10.1097\/01.jnen.0000263867.46070.e2","journal-title":"J Neuropathol Exp Neurol"},{"key":"4860_CR57","doi-asserted-by":"publisher","first-page":"368","DOI":"10.1016\/j.brainres.2015.06.034","volume":"1622","author":"N Valero","year":"2015","unstructured":"Valero N, Mosquera J, Alcocer S, Bonilla E, Salazar J, \u00c1lvarez-Mon M (2015) Melatonin, minocycline and ascorbic acid reduce oxidative stress and viral titers and increase survival rate in experimental Venezuelan equine encephalitis. Brain Res 1622:368\u2013376. https:\/\/doi.org\/10.1016\/j.brainres.2015.06.034","journal-title":"Brain Res"},{"key":"4860_CR58","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v11080739","volume":"11","author":"SS Bawage","year":"2019","unstructured":"Bawage SS, Tiwari PM, Pillai S, Dennis VA, Singh SR (2019) Antibiotic minocycline prevents respiratory syncytial virus infection. Viruses 11:1\u201310. https:\/\/doi.org\/10.3390\/v11080739","journal-title":"Viruses"},{"key":"4860_CR59","doi-asserted-by":"publisher","first-page":"109271","DOI":"10.1016\/j.biopha.2019.109271","volume":"118","author":"YT Liao","year":"2019","unstructured":"Liao YT, Wang SM, Chen SH (2019) Anti-inflammatory and antiviral effects of minocycline in enterovirus 71 infections. Biomed Pharmacother 118:109271. https:\/\/doi.org\/10.1016\/j.biopha.2019.109271","journal-title":"Biomed Pharmacother"},{"key":"4860_CR60","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.compbiolchem.2017.06.003","volume":"70","author":"A Sharifi","year":"2017","unstructured":"Sharifi A, Amanlou A, Moosavi-Movahedi F, Golestanian S, Amanlou M (2017) Tetracyclines as a potential antiviral therapy against Crimean Congo hemorrhagic fever virus: docking and molecular dynamic studies. Comput Biol Chem 70:1\u20136. https:\/\/doi.org\/10.1016\/j.compbiolchem.2017.06.003","journal-title":"Comput Biol Chem"},{"key":"4860_CR61","doi-asserted-by":"publisher","first-page":"516","DOI":"10.1038\/nature01850","volume":"424","author":"A Takaoka","year":"2003","unstructured":"Takaoka A, Hayakawa S, Yanai H (2003) Integration of interferon alpha\/beta signalling to p53 responses in tumour suppression and antiviral defence. Nature 424:516\u2013523. https:\/\/doi.org\/10.1038\/nature01850","journal-title":"Nature"},{"key":"4860_CR62","doi-asserted-by":"publisher","first-page":"8802","DOI":"10.1128\/JVI.79.14.8802-8811.2005","volume":"79","author":"E Turpin","year":"2005","unstructured":"Turpin E, Luke K, Jone J (2005) Influenza virus infection increases p53 activity: role of p53 in cell death and viral replication. J Virol 79:8802\u20138811. https:\/\/doi.org\/10.1128\/JVI.79.14.8802-8811.2005","journal-title":"J Virol"},{"key":"4860_CR63","doi-asserted-by":"publisher","first-page":"27549","DOI":"10.1074\/jbc.M313435200","volume":"279","author":"S Fujioka","year":"2004","unstructured":"Fujioka S, Schmidt C, Sclabas GM, Li Z, Pelicano H, Peng B, Yao A, Niu J, Zhang W, Evans DB, Abbruzzese JL, Huang P, Chiao PJ (2004) Stabilization of p53 is a novel mechanism for proapoptotic function of NF-\u03baB. J Biol Chem 279:27549\u201327559. https:\/\/doi.org\/10.1074\/jbc.M313435200","journal-title":"J Biol Chem"},{"key":"4860_CR64","doi-asserted-by":"publisher","first-page":"fnv195","DOI":"10.1093\/femsle\/fnv195","volume":"362","author":"ZC Wu","year":"2015","unstructured":"Wu ZC, Wang X, Wei JC, Li BB, Shao DH, Li YM, Liu K, Shi YY, Zhou B, Qiu YF, Ma ZY (2015) Antiviral activity of\u00a0doxycycline\u00a0against vesicular stomatitis virus in vitro. FEMS Microbiol Lett 362:fnv195. https:\/\/doi.org\/10.1093\/femsle\/fnv195","journal-title":"FEMS Microbiol Lett"},{"key":"4860_CR65","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/femsle\/fnx170","volume":"364","author":"Y Li","year":"2017","unstructured":"Li Y, Wu Z, Liu K, Qi P, Xu J, Wei J, Li B, Shao D, Shi Y, Qiu Y, Ma Z (2017) Doxycycline enhances adsorption and inhibits early-stage replication of porcine reproductive and respiratory syndrome virus in vitro. FEMS Microbiol Lett 364:1\u20136. https:\/\/doi.org\/10.1093\/femsle\/fnx170","journal-title":"FEMS Microbiol Lett"},{"key":"4860_CR66","doi-asserted-by":"publisher","first-page":"287","DOI":"10.1016\/j.yexmp.2012.03.003","volume":"92","author":"HH Ng","year":"2012","unstructured":"Ng HH, Narasaraju T, Phoon MC, Sim MK, Seet JE, Chow VT (2012) Doxycycline treatment attenuates acute lung injury in mice infected with virulent influenza H3N2 virus: involvement of matrix metalloproteinases. Exp Mol Pathol 92:287\u2013295. https:\/\/doi.org\/10.1016\/j.yexmp.2012.03.003","journal-title":"Exp Mol Pathol"},{"key":"4860_CR67","doi-asserted-by":"publisher","first-page":"e0126360","DOI":"10.1371\/journal.pone.0126360","volume":"10","author":"HA Rothan","year":"2015","unstructured":"Rothan HA, Bahrani H, Mohamed Z, Teoh TC, Shankar EM, Rahman NA, Yusof R (2015) A combination of doxycycline and ribavirin alleviated chikungunya infection. PLoS ONE 10:e0126360. https:\/\/doi.org\/10.1371\/journal.pone.0126360","journal-title":"PLoS ONE"},{"key":"4860_CR68","first-page":"681","volume":"30","author":"HA Rothan","year":"2013","unstructured":"Rothan HA, Buckle MJ, Ammar YA, Mohammadjavad P, Shatrah O, Noorsaadah AR, Rohana Y (2013) Study the antiviral activity of some derivatives of tetracycline and non-steroid anti-inflammatory drugs towards dengue virus. Trop Biomed 30:681\u2013690","journal-title":"Trop Biomed"},{"key":"4860_CR69","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1007\/s00705-013-1880-7","volume":"159","author":"HA Rothan","year":"2014","unstructured":"Rothan HA, Mohamed Z, Paydar M, Rahman NA, Yusof R (2014) Inhibitory effect of doxycycline against dengue virus replication in vitro. Arch Virol 159:711\u2013718. https:\/\/doi.org\/10.1007\/s00705-013-1880-7","journal-title":"Arch Virol"},{"key":"4860_CR70","doi-asserted-by":"publisher","first-page":"e428","DOI":"10.1371\/journal.pone.0000428","volume":"2","author":"JM Yang","year":"2007","unstructured":"Yang JM, Chen YF, Tu YY, Yen KR, Yang YL (2007) Combinatorial computational approaches to identify tetracycline derivatives as flavivirus inhibitors. PLoS ONE 2:e428. https:\/\/doi.org\/10.1371\/journal.pone.0000428","journal-title":"PLoS ONE"},{"issue":"4","key":"4860_CR71","doi-asserted-by":"publisher","first-page":"387","DOI":"10.1128\/cmr.5.4.387","volume":"5","author":"BS Speer","year":"1992","unstructured":"Speer BS, Shoemaker NB, Salyers AA (1992) Bacterial resistance to tetracycline: mechanisms, transfer, and clinical significance. Clin Microbiol Rev 5(4):387\u2013399. https:\/\/doi.org\/10.1128\/cmr.5.4.387","journal-title":"Clin Microbiol Rev"},{"key":"4860_CR72","doi-asserted-by":"publisher","first-page":"124","DOI":"10.1139\/O08-002","volume":"86","author":"B Zakeri","year":"2008","unstructured":"Zakeri B, Wright GD (2008) Chemical biology of tetracycline antibiotics. Biochem Cell Biol 86:124\u2013136. https:\/\/doi.org\/10.1139\/O08-002","journal-title":"Biochem Cell Biol"},{"key":"4860_CR73","doi-asserted-by":"publisher","first-page":"291","DOI":"10.1002\/hep.20069","volume":"39","author":"A Humar","year":"2004","unstructured":"Humar A, McGilvray I, Phillips MJ, Levy GA (2004) Severe acute\n respiratory syndrome and the liver. Hepatology 39:291\u2013294. https:\/\/doi.org\/10.1002\/hep.20069","journal-title":"Hepatology"},{"key":"4860_CR74","doi-asserted-by":"publisher","DOI":"10.1021\/acs.jcim.0c00179","author":"J Wang","year":"2020","unstructured":"Wang J (2020) Fast identification of possible drug treatment of coronavirus disease-19 (COVID-19) through computational drug repurposing study. J Chem Inf Model. https:\/\/doi.org\/10.1021\/acs.jcim.0c00179 (Online ahead of print)","journal-title":"J Chem Inf Model"},{"key":"4860_CR75","doi-asserted-by":"publisher","first-page":"6511","DOI":"10.18632\/aging.103001","volume":"12","author":"C Sargiacomo","year":"2020","unstructured":"Sargiacomo C, Sotgia F, Lisanti MP (2020) COVID-19 and chronological aging: senolytics and other anti-aging drugs for the treatment or prevention of corona virus infection? Aging (Albany NY) 12:6511\u20136517. https:\/\/doi.org\/10.18632\/aging.103001","journal-title":"Aging (Albany NY)"},{"key":"4860_CR76","doi-asserted-by":"publisher","first-page":"487","DOI":"10.1002\/phar.2395","volume":"40","author":"M Sodhi","year":"2020","unstructured":"Sodhi M, Etminan M (2020) Therapeutic potential for tetracyclines in the treatment of COVID-19. Pharmacotherapy 40:487\u2013488. https:\/\/doi.org\/10.1002\/phar.2395","journal-title":"Pharmacotherapy"},{"key":"4860_CR77","doi-asserted-by":"publisher","first-page":"e114457","DOI":"10.1371\/journal.pone.0114457","volume":"9","author":"H Song","year":"2014","unstructured":"Song H, Fares M, Maguire KR, Sid\u00e9n A, Pot\u00e1cov\u00e1 Z (2014) Cytotoxic effects of tetracycline analogues (doxycycline, minocycline and COL-3) in acute myeloid leukemia HL-60 cells. PLoS ONE 9:e114457. https:\/\/doi.org\/10.1371\/journal.pone.0114457","journal-title":"PLoS ONE"},{"key":"4860_CR78","doi-asserted-by":"publisher","first-page":"336","DOI":"10.1016\/j.tiv.2018.03.012","volume":"50","author":"C Ruiz-Moreno","year":"2018","unstructured":"Ruiz-Moreno C, Velez-Pardo C, Jimenez-Del-Rio M (2018) Minocycline induces apoptosis in acute lymphoblastic leukemia Jurkat cells. Toxicol In Vitro 50:336\u2013346. https:\/\/doi.org\/10.1016\/j.tiv.2018.03.012","journal-title":"Toxicol In Vitro"},{"key":"4860_CR79","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1099\/0022-1317-79-8-1833","volume":"79","author":"V O'Brien","year":"1998","unstructured":"O\u2019Brien V (1998) Viruses and apoptosis. J Gen Virol 79:1833\u20131845. https:\/\/doi.org\/10.1099\/0022-1317-79-8-1833","journal-title":"J Gen Virol"},{"key":"4860_CR80","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41423-020-0485-9","volume":"18","author":"Y Ren","year":"2020","unstructured":"Ren Y, Shu T, Wu D, Mu J, Wang C, Huang M, Han Y, Zhang XY, Zhou W, Qiu Y, Zhou X (2020) The ORF3a protein of SARS-CoV-2 induces apoptosis in cells. Cell Mol Immunol 18:1\u20133. https:\/\/doi.org\/10.1038\/s41423-020-0485-9","journal-title":"Cell Mol Immunol"},{"key":"4860_CR81","unstructured":"Bangladesh Medical Research Council (BMRC) (2020) Efficacy and Safety of Ivermectin and Doxycycline in Combination or IVE Alone in Patients With COVID-19 Infection. ClinicalTrials.gov Identifier: NCT04407130. NIH. U.S. National Library of Medicine"},{"key":"4860_CR82","doi-asserted-by":"publisher","first-page":"365","DOI":"10.1038\/s41586-020-2008-3","volume":"579","author":"F Wu","year":"2020","unstructured":"Wu F, Zhao S, Yu B, Chen YM, Wang W, Song ZG, Hu Y, Tao ZW, Tian JH, Pei YY, Yuan ML, Zhang YL, Dai FH, Liu Y, Wang QM, Zheng JJ, Xu L, Holmes EC, Zhang YZ (2020) A new coronavirus associated with human respiratory disease in China. Nature 579:365\u2013369. https:\/\/doi.org\/10.1038\/s41586-020-2008-3","journal-title":"Nature"}],"container-title":["Archives of Virology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00705-020-04860-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00705-020-04860-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,1,20]],"date-time":"2021-01-20T04:52:40Z","timestamp":1611118360000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00705-020-04860-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,11,2]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["4860"],"URL":"https:\/\/doi.org\/10.1007\/s00705-020-04860-8","relation":{},"ISSN":["0304-8608","1432-8798"],"issn-type":[{"value":"0304-8608","type":"print"},{"value":"1432-8798","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,11,2]]},"assertion":[{"value":"22 June 2020","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"13 September 2020","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 November 2020","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standard"}},{"value":"No potential conflict of interest is reported by the authors.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}},{"value":"This content has been made available to all.","name":"free","label":"Free to read"}]}}